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Executive Summary 
 
Promoting and protecting the health of Iowans is the mission of the Iowa Department of Public Health 
(IDPH). Surveillance of notifiable health conditions is essential in establishing what, how, and when 
events impact the public’s health. Multiple divisions and bureaus are dedicated to accomplishing the 
goals of surveillance. In 2011, there were more than 60,000 laboratory results of infectious diseases and 
conditions submitted to IDPH disease surveillance programs. IDPH also investigates non-infectious 
conditions related to lead, occupational, and environmental hazards like carbon monoxide. 
Approximately 92,000 blood lead test results were reported to IDPH in 2011. 
 
Crucial partners contributing to the surveillance and reduction of disease include the State Hygienic 
Laboratory (SHL) at the University of Iowa, city and county public health agencies, and health 
professionals.  
 
In 2011, the number of the vaccine-preventable diseases decreased when compared to the previous 
three year average (2008-2010).  
 
Enteric diseases like campylobacteriosis, cryptosporidiosis, listeriosis, E. coli and other shiga-toxin-
producing strains showed increases when compared to the previous three year average, while giardiasis, 
salmonellosis, and shigellosis showed decreases.  
 
Diseases spread via insects and other vectors continue to impact Iowans. In 2011, there was a notable 
number of these diseases that were detected and reported to IDPH including Dengue fever, 
ehrlichiosis/anaplasmosis, Lyme disease, malaria, Rocky Mountain spotted fever, and West Nile virus. 
 
While the number of gonorrhea and syphilis diagnoses remains relatively stable, diagnoses of chlamydial 
infections continue to increase. The number of newly diagnosed Human immunodeficiency virus (HIV) 
cases increased when compared to the average number of diagnoses for the previous five years. The 
increase in HIV diagnoses is primarily among males, who have accounted for 83 percent of all diagnoses 
since 2007. Half of new HIV diagnoses occur in persons ages 25 through 44 years. However, it is 
important to note that diagnoses among persons 15 to 24 years of age rose to 28 in 2011, seven more 
than in 2010, and four times the number reported in 2003. The data also continue to show a 
disproportionate number of diagnoses among non-Hispanic African Americans and Hispanics. Non-
Hispanic African Americans were about three percent of Iowa’s general population, but accounted for 
20 percent of new HIV diagnoses. While making up five percent of Iowa’s general population, Hispanics 
accounted for 13 percent of new HIV diagnoses. 
 
Great strides were made in improving surveillance for carbon monoxide poisoning and for lead exposure 
in young children. These data have already begun to help shape new policies including a legislative 
requirement for children to have completed lead screening prior to kindergarten entry.  
 
There were also 40 outbreaks with 526 people affected that were reported and investigated in 2011. 
The most common pathogen implicated was norovirus and the common places where the outbreaks 
occurred include restaurants, long-term care/assisted living facilities, schools, and homes.  
 
Approximately 600 health workers reported diseases through the Iowa Disease Surveillance System; a 
system that is now capable of receiving electronic laboratory results on a daily basis. Iowa’s surveillance 
systems are becoming increasingly streamlined, electronically and web-based, and interconnected. As 
progress in assessing disease improves every year, IDPH and its partners will keep moving forward in 
promoting and protecting the health of Iowans.  
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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The Iowa Department of Public would like to take this opportunity to thank all of its partners including 
local public health agencies, clinical laboratories, hospitals, clinics, healthcare providers, infection 
preventionists, long-term health care facilities, schools, and other health professionals for their 
continued support of the Iowa disease surveillance.   
Table 1. Summary of common, notifiable diseases, 2008-2011 and percent change in number of cases 
reported compared to a three-year average 
  2008 2009 2010 
3-yr average 
2008-2010 2011 
Percent 
change† 
  Number of cases ǂ    
Campylobacteriosis 591 552 751 631 747 18.3% 
Chlamydia 9372 9406 10542 9773 10928 11.8% 
Cryptosporidiosis 284 232 397 304 364 19.6% 
E. coli and other shiga-toxin producing  208 163 173 181 189 4.2% 
Giardiasis 326 291 284 300 271 -9.8% 
Gonorrhea 1700 1658 1804 1721 1966 14.3% 
Hepatitis A 109 38 11 53 8 -84.8% 
Hepatitis B, acute 25 38 15 26 15 -42.3% 
HIV (new diagnoses) 101 126 114 114 120 5.6% 
lead poisoning (adult) 883 694 736 771 832 7.9% 
Legionellosis 21 24 16 20 11 -45.9% 
Lyme disease 109 108 87 101 100 -1.3% 
Meningococcal invasive disease 19 16 10 15 14 -6.7% 
Mumps 24 15 38 26 8 -68.8% 
Pertussis (whooping cough) 257 235 705 399 232 -41.9% 
Salmonellosis 425 408 530 454 448 -1.4% 
Shigellosis 214 53 57 108 18 -83.3% 
Syphilis 75 65 68 69 70 1.0% 
†The percent change is calculated by subtracting the 3-year average from the total cases for 2011 and dividing by the absolute 
value of the 3-year average.  
ǂ Table includes all confirmed and probable cases.  
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Introduction 
The purpose of this report is to provide an overall snapshot of the types and trends of notifiable and 
other diseases that occur in Iowa. When possible, details specific to the disease are provided, including 
information on which serotypes or groups were prevalent and which strains caused outbreaks. 
Comparisons to national rates are provided whenever possible. Aggregated county-level data are 
provided in a table at the end of the report. The report is intended for public, media, public health, and 
health care use at all levels.  
 
The report is divided into the following sections: respiratory and vaccine-preventable diseases, sexually-
transmitted diseases, Human immunodeficiency virus (HIV)/Acquired immunodeficiency syndrome 
(AIDS), hepatitis C, enteric diseases, zoonotic diseases, rare and unusual diseases, and environmental 
health conditions.  
 
The Iowa Department of Public Health (IDPH) has seven divisions and of those, three contributed 
disease data to this report, including the Division of Behavioral Health (BH), Acute Disease Prevention 
and Emergency Response (ADPER), and Environmental Health (EH). Two bureaus within ADPER are 
responsible for infectious disease investigation- the Center for Acute Disease Epidemiology (CADE) and 
the Bureau of Immunization and Tuberculosis (BIT).  
 
CADE conducts surveillance for common and emerging infectious diseases, agents of bioterrorism, 
disease outbreaks, and occurrence of rare and unusual acute diseases. BIT conducts surveillance of 
tuberculosis and perinatal hepatitis B, as well as coordinates the immunization program for the state. 
Specific disease conditions are reportable to the department per Iowa Administrative Code 641, Chapter 
1. The urgency tied to reporting varies by disease1. 
 
The Division of Environmental Health has three bureaus: the Bureau of Radiological Health, Bureau of 
Lead Poisoning Prevention (BLPP), and the Bureau of Environmental Health Services (BEHS). Each bureau 
has distinct goals and objectives and is comprised of very diverse programs. Certain health conditions of 
environmental origin are required to be reported to IDPH per Iowa Administrative Code 641, Chapter 1. 
The content in this report includes data from BEHS, which includes disease/outbreak surveillance with 
the EHS‐Net program and surveillance on carbon monoxide poisoning and methemoglobinemia. Data 
from the BLPP includes all reports of childhood and adult blood lead levels, reports of other heavy metal 
poisonings, pesticide poisonings, and reports of fatal work-related injuries.  
 
The Division of Behavioral Health includes the Bureau of HIV, Sexually Transmitted Disease (STD), and 
Hepatitis. This bureau prevents, identifies, monitors, and supports persons with HIV/AIDS, STDs, or viral 
hepatitis. Disease reporting and tracking are a large component of the work accomplished by this 
bureau, as is locating, counseling, and testing partners of persons with sexually transmitted diseases.  
 
Public health emergency response planning plays a major role in preparing IDPH to respond to events of 
public health significance. The department has used an incident management system in several events 
such as the severe weather in 2008 and the 2009 H1N1 pandemic. Preparedness planning at both the 
state and local levels has greatly improved the way public health responds to large-scale disease 
outbreaks.  
 
This report provides an overview of disease investigations and represents only a fraction of work 
accomplished by IDPH staff each year. The time invested in each disease report varies greatly by disease 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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and nature of the report. Some reports require a quick database query and update of an electronic file. 
Others require hours of staff time in contact tracing, mentoring and assisting other health investigators, 
and communication, education, and intervention implementation.  
 
Support for the initiatives of both divisions stem from federal and state allocations and grants. The TB, 
STD, and HIV/AIDS surveillance programs are funded under separate cooperative agreements with the 
Centers for Disease Control and Prevention (CDC) and the National Center for HIV/AIDS, Viral Hepatitis, 
STD and TB Prevention. 
 
Methods 
Disease reports are submitted to IDPH via phone, fax, mail, or a secure electronic reporting system. 
Reporters include health care providers, hospitals, local public health agencies, laboratories and the 
public. The reports received are on Iowa residents; however acquisition or exposure to a certain 
illnesses may have occurred in Iowa, in another state, or outside of the United States. 
 
Reports received by CADE are tracked in the secure web-based Iowa Disease Surveillance System (IDSS). 
De-identified data are electronically exchanged between IDSS and CDC. Electronic laboratory reports are 
sent from the State Hygienic Laboratory (SHL) at the University of Iowa directly to IDSS daily.   
 
Cases of acute, infectious disease are typically referred to local public health agencies for patient 
investigation and interview. Agencies primarily use IDSS to report information back to IDPH.  
 
Local public health agencies are critical in conducting outbreak investigations. These agencies work to 
identify, investigate, and contain outbreaks at the city and county level.  
 
A few diseases require a secondary reporting system used by IDPH in transmitting data to program-
specific staff at CDC. These diseases include influenza and West Nile virus. The National Outbreak 
Reporting System is a CDC-sponsored system used by IDPH to report outbreaks.  
 
Rates were calculated using the 2010 census population for the State of Iowa or the appropriate 
estimated census year. Five-year average values used in the graphs in the summary of enteric disease 
were calculated by adding two standard deviations to the five-year average. Calculations were 
performed with SPSS 16 ®, SAS, and Microsoft® Excel. Maps were generated using ARC GIS ®.  
 
CADE uses the most recent Council of State and Territorial Epidemiologists (CSTE)/CDC case definitions 
found at www.cdc.gov/epo/dphsi/casedef/case_definitions.htm. CSTE/CDC definitions are used to 
classify the case as confirmed, probable, suspect, not a case, or awaiting more information. Only 
confirmed and probable cases meeting the CSTE/CDC definitions are included in this report.  
 
Disease case counts and Iowa-specific case demographics were retrieved from IDSS, which is maintained 
within CADE. The specific file used for this report was created in May 2011. Case reports and additional 
information that may have altered the disease counts received after this date were not included in this 
report. In addition, the data file was generated using MMWR (Morbidity Mortality Weekly Report) year 
2011. Therefore, case counts in this report may vary slightly from counts generated using the calendar 
year of 2011. 
 
Influenza surveillance data were collected from multiple sources, including outpatient health care 
providers, hospitals, public health, clinical laboratories, and schools. Laboratory-confirmed influenza 
cases were largely based on real-time polymerase chain reaction (RT-PCR) test results sent from SHL. 
Iowa Department of Public Health 
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Influenza-associated hospitalizations were also reported from the sentinel hospitals that participated in 
the Influenza Surveillance Network (IISN).  
 
Respiratory syncytial virus (RSV) rapid antigen test data are used to determine the weekly positive 
predictive value of the rapid antigen tests in Iowa. SHL surveyed clinical and reference labs throughout 
the state for the number of rapid-antigen tests performed and number positive weekly and sent the 
survey results to IDPH. 
 
The surveillance case definitions for HIV, AIDS, STDs, and TB are those developed by CSTE/CDC. 
Surveillance is conducted according to detailed guidelines developed. Several programs enter data into 
CDC-developed software programs. Programs transfer data via a secure data network on a weekly or 
monthly basis. HIV/AIDS data are collected in a software program called the HIV/AIDS Reporting System 
or eHARS. 
 
For accuracy of analysis, and because jurisdiction for HIV and AIDS cases is determined by the person’s 
residence at the time of diagnosis, great care is taken both within and between states to maintain 
unduplicated databases for HIV and AIDS. 
 
With regard to HIV/AIDS surveillance, reports are generated semi-annually, and as needed. An 
epidemiological profile is produced every three years, with annual interim updates2. HIV/AIDS data 
analysis for this report used a combination of CDC’s eHARS software, Microsoft® Excel, SAS® and SAS® 
Enterprise Guide.  
 
In 2010, the STD program began using IDSS for surveillance of syphilis, Chlamydia, and gonorrhea. Prior 
to 2010, the STD program entered data in a CDC database called STD*MIS or the STD Management 
Information System.  
 
The results of blood lead testing done on all Iowa citizens are required to be reported to the Bureau of 
Lead Poisoning Prevention. Data are entered into the CDC database STELLAR. BLPP exports data from 
STELLAR to CDC on a quarterly basis per programming developed by CDC. IDPH also analyzes STELLAR 
data on a quarterly basis. The analyses and reports are produced in Microsoft Access and Microsoft 
Excel.   
 
Most disease-specific data are transmitted to CDC electronically on a routine basis after being de-
identified. Some disease information is communicated at the request of CDC. The statistics reported by 
ADPER programs to CDC are used to develop a composite picture of disease burden in the US.  
 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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Summary of respiratory and vaccine-preventable diseases 
 
Haemophilus influenzae B 
Cases of Haemophilus influenzae type B (Hib), invasive disease are rare in Iowa and the US. In 1991, Hib 
vaccine was recommended for all infants after age two months. Since then, the incidence of Hib in 
children less than five years of age has declined by greater than 99 percent. In 2011, three cases of 
Haemophilus influenzae type B were reported to IDPH. One occurred in a 68 year-old male with no Hib 
vaccination, one in a 34 year-old female with unknown Hib vaccination and one in a 12 year-old female 
with no Hib vaccination.  
 
Hepatitis A 
See Summary Enteric Disease Section. 
 
Hepatitis B (acute and chronic) 
Hepatitis B is a contagious liver disease that results from infection with the hepatitis B virus. It can be 
either acute or chronic. Acute hepatitis B virus infection is a short-term illness that occurs within the first 
six months after someone is exposed to the virus. Chronic hepatitis B virus infection is a long-term 
illness that occurs when the virus remains in a person’s body. Chronic hepatitis B is a serious disease 
that can result in long-term health problems, and even death. 
 
A total of 15 cases, or 0.5 cases for every 100,000 persons, of acute hepatitis B were reported to CADE in 
2011. Eighty-seven percent of the cases were males. Nationally, acute hepatitis B infections occur 1.8 
times more often in men than in women.  
 
The Centers for Disease Control and Prevention (CDC) estimates there were 43,000 new hepatitis B 
infections in the U.S. in 2007. CDC estimates that there are between 800,000 and 1.4 million people 
living with chronic hepatitis B disease in the US. 
 
There were 182 confirmed or probable chronic hepatitis B cases reported in 2011 in Iowa.  
 
Influenza  
The Iowa Influenza Surveillance Network (IISN) tracks influenza activity, age groups impacted, outbreaks, 
virus type and strain, and severity of seasonal influenza. During the 2011-2012 season, over 250 
surveillance sites reported to IISN, including medical clinics, hospitals, laboratories, schools, local public 
and health departments. IDPH analyzed the data reported from the surveillance sites and published the 
influenza weekly report during the season. To see the weekly report, visit 
www.idph.state.ia.us/IdphArchive/Archive.aspx?channel=FluReports 
 
The 2011-2012 influenza season had a mild level of activity compared to most non-pandemic influenza 
seasons in Iowa.  The first case of seasonal influenza was confirmed by the State Hygienic Laboratory 
(SHL) in November, 2011 and influenza activity remained low through December and increased in 
January and February before peaking in mid-March (Figure 1). SHL identified three seasonal influenza 
viruses circulating in Iowa-influenza A (H3), influenza A (H1N1) pdm09 and influenza B. Influenza A (H3) 
viruses were predominant in Iowa, accounting for 85 percent of all positive influenza specimens tested.  
 
Influenza-associated hospitalizations were reported from 26 sentinel hospitals during the season 
(Figure2). Most of the hospitalizations occurred in people younger than five years of age and older than 
64 years of age. 
Iowa Department of Public Health 
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Figure 1. Laboratory-confirmed cases of influenza reported to IDPH, 2011-2012 
 
 
Figure 2. Influenza-associated hospitalization by age group, 2011-2012 
Measles 
There was one confirmed case of measles reported to IDPH in 2011. This case occurred in an child 
between 0-18 years of age.  
 
Meningococcal invasive disease 
In 2011, there were 14 confirmed and probable cases or 0.5 cases for every 100,000 persons in Iowa. 
The age of case patients ranged from zero to 87 years old with the mean age of 49 years. Nationally, 
there are 0.36 cases for every 100,000 persons.  
 
Of these cases, six were group B, four were 
group Y, two were W135, and two were 
undetermined (Table 2).  
 
 
Table 2. Cases of meningococcal disease by 
serogroups, 2011 
A B* C W135 Y Unk 
0    6 0 2 4 2 
*Serogroup B is not covered by the meningococcal vaccine
CDC defines a community-based outbreak of meningitis as the occurrence of three or more confirmed or 
probable cases during a period of less than or equal to three months among persons residing in the 
same area who are not close contacts of each other and who do not share a common affiliation, with a 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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primary attack rate of at least 10 cases per 100,000 population3. There were no outbreaks in Iowa in 
2011.  
 
Meningococcal invasive disease is fatal in 10-14 percent of cases; however, no Iowa case was fatal in 
2011. There are two types of meningococcal-vaccines currently licensed for use in the US:  1) a 
polysaccharide vaccine and 2) a conjugated vaccine. 
 
Mumps 
In 2011, there were seven cases of mumps or 0.3 cases per 100,000 persons, a 68.8 percent decrease 
over the previous three year average of 26. Case ages in 2011 ranged from five to 47 years with a 
median age of 22.5 years. There were no outbreaks in Iowa in 2011. 
 
In 2006, Iowa was the center of the largest mumps outbreak in 20 years in the US with 1,963 confirmed 
and probable cases. Prior to 2006, most cases were typically imported from countries with endemic 
disease.  
 
Pertussis (Whooping cough) 
Pertussis is caused by Bordetella pertussis and typically causes epidemics every three to five years. In 
2011, there were 232 confirmed and probable cases reported to IDPH or 7.6 cases for every 100,000 
persons in Iowa, which accounts for a 67.1 percent decrease in activity over the previous three-year 
average. High levels of activity also occurred in 2004 and 2005 (Figure 3). 
 
Nearly half (45%) of 2011 cases occurred in children ages 0 to fourteen years, and especially children 
ages ≤ four. Four percent of pertussis cases were hospitalized. The highest numbers of cases were 
reported in the eastern region of the state. 
 
The most common symptoms are paroxysms (fits of coughing), followed by posttussive vomiting, 
whooping, and apnea. Rare, but serious secondary conditions reported included pneumonia, 
encephalopathy and seizures. 
 
Figure 3. Number of pertussis cases reported to IDPH by month and year, 2003-2011 
 
Respiratory Syncytial Virus (RSV) 
Sentinel surveillance for respiratory syncytial virus began in 2008. IDPH and SHL solicit rapid RSV test 
results from clinical and reference labs throughout the state to determine the percentage of positive 
test results of those performed (Figure 4). In addition, various labs including SHL report polymerase 
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chain reaction (PCR) or culture confirmation of RSV as a means to verify the presence of RSV in Iowa. 
The typical RSV season in Iowa extends from December through May. 
 
Nationally, RSV surveillance is conducted by CDC using data from the National Respiratory and Enteric 
Virus Surveillance System. Data are reported from sentinel laboratories throughout the US on a 
voluntary basis. Recent research has highlighted variability among different regions and states in the 
US4.  
Figure 4. Percent of rapid RSV tests positive and number of tests performed, 2011-2012 
 
 
Tuberculosis (TB) 
In 2011, Iowa reported 40 cases of 
active TB disease. Since 2002, Iowa 
averaged almost 44 cases of TB each 
year (Figure 5). Although case rates are 
declining, many cases have existing co-
morbidities that make TB treatment 
considerably more complex and require 
extensive care, including the use of 
second line drugs. Treatment with 
second line drugs is complicated and 
expensive, requiring expert consultation 
and extended treatment durations.  
  
Counties with larger population centers 
such as Polk, Woodbury and Black Hawk 
report the majority of TB 
cases. However, as Figure 6 illustrates, 
many (55/99) Iowa counties reported TB 
cases during calendar years 1999-2008.  
 
The 2011, TB case rate for Iowa is 1.3 
cases per 100,000 persons. This is 
significantly lower than the national 
average of 3.6 cases per 100,000 
persons. Iowa owes its low TB case rate 
in part to proficient contact 
Figure 6. Iowa Counties with TB cases 1999-2008 
 
Figure 5. Number of Iowa TB cases per year, 2002-2011 
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investigations, healthcare providers observance of treatment guidelines, adherence to the Directly 
Observed Therapy for active disease cases and the provision of medication for latent TB infections to 
thousands of Iowans annually. 
 
The proportion of reported TB cases in 
non-US born persons has increased 
significantly in the past two decades. In 
1995, for example, non-U.S. born persons 
accounted for 38 percent of reported TB 
cases Iowa. From 2002 – 2011, non-US 
born persons accounted for 66 percent 
of reported TB cases Iowa (Figure7). Non-
US born persons account for only four 
percent of the Iowa population, 
highlighting the disparity. The decreasing 
numbers of US-born cases are due, in 
part, to effective TB control practices in 
this country.  
 
In many parts of the developing world, TB is still widespread and remains a leading cause of death. 
Immigration of people from these countries to the United States illustrates that what happens in one 
part of the world directly impacts other parts of the world. Effective targeted testing programs for newly 
arriving refugees, immigrants, and students play a major role in identifying and treating these 
populations.  
 
Country of Origin Data  
For 2011, 29 individuals emigrating from 
15 countries (excludes US) developed TB 
in Iowa. Figure 8 represents 290 
individuals, emigrating from 47 countries 
(excludes US) who developed TB disease 
after their arrival to Iowa 2002-2010. As 
the map illustrates, TB anywhere is TB 
everywhere. Approximately 95 percent 
of all patients with active TB disease live 
in the developing world, where 99 
percent of all TB deaths occur. TB is a 
good example of the global nature of 
public health. It is important to implement consistent and aggressive public health measures to halt TB 
disease, which left untreated, kills half of its victims. 
 
For a detailed overview of TB, see the www.idph.state.ia.us/ImmTB/TB.aspx?prog=Tb&pg=TbHome 
 
 
 
Figure 7. Percent of US born versus non-US born TB cases 
in Iowa 2002-2011 
 
Figure 8: Iowa TB cases by country of origin 2002-2010 
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Summary of sexually transmitted diseases, HIV and AIDS, and hepatitis C, 
 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNODEFICIENCY 
SYNDROME (AIDS) 
Although there has been some year to year fluctuation, HIV diagnoses have been increasing at a rate of 
about three each year since 2000. There were 120 HIV diagnoses in 2011, an increase of six (five %) from 
the 114 diagnoses reported in 2010 and also higher than the average of 115 for the previous five years. 
There were 3.9 HIV diagnoses per 100,000 population in 2011, compared to 3.7 HIV diagnoses per 
100,000 population in 2010 and 4.1 HIV diagnoses per 100,000 population in 2009. Figure 9 charts the 
number of HIV diagnoses by year for the years 2000 through 2011. 
 
While males have always accounted for the majority of HIV diagnoses, this has become even more 
pronounced since 2003. Diagnoses among males had increased steadily, from 56 in 2003 to 105 in 2007. 
Since then, the number of diagnoses 
was fluctuated, averaging 96 per year 
from 2008 through 2011. There were 
100 diagnoses among males in 2011. 
In contrast, the number of diagnoses 
among females decreased from 33 in 
2003 to 19 in 2006 and has averaged 
19.5 per year since then. There were 
20 females diagnosed in 2011. The 
proportion of diagnoses in males has 
stabilized at around 83 percent (about 
five males for every female) since 
2007. This is in contrast to 75 percent 
male (three males to one female) 
from 2003 through 2006.  
 
Diagnoses of HIV among the foreign born have declined from the 10‐year high recorded in 2002 when 
32 (30%) of the 105 persons diagnosed with HIV were foreign born. By comparison, 27 (22.5%) of the 
120 persons diagnosed in 2011 were born in a country other than the United States (or one of its 
dependencies).  
 
The gradual increase in HIV diagnoses since 2000 is largely attributed to increases in diagnoses among 
males, and in particular, among those 13 to 24 years of age and 45 years of age and older. For the past 
three years, diagnoses among persons 13 to 24 years of age have numbered 20 or more. Twenty‐eight 
persons between the ages of 13 to 24 years were diagnosed in 2011, an increase of 7 (33%) from the 21 
diagnoses in 2010, and four times the diagnoses recorded in 2003. While this is concerning, it is 
important not to lose sight of the fact that diagnoses among persons 25 to 44 years of age accounted for 
half of all diagnoses, with 61 persons diagnosed in 2011. The number of diagnoses among persons 45 
years and older, which had increased steadily from 18 in 2003 to a peak of 39 in 2007, decreased 
slightly, from 33 in 2010 to 30 in 2011. There was one pediatric HIV diagnosis in 2011, a child born to an 
HIV‐infected mother.  
  
For persons 13 years of age and older (adults and adolescents), the median age at diagnosis in 2011 was 
34 years. Adult/adolescent males, whose median age at diagnosis was 35 years, tended to be slightly 
older than females whose median age was 31 years. There were 24 diagnoses in 2011 among 
 Figure 9. Number of HIV diagnoses by year, 2000 -2011 
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non‐Hispanic African Americans, a decrease of six (20%) from 30 diagnoses in 2010, and near the four 
year average of 22 from 2007 through 2010. While non‐Hispanic African-Americans made up almost 3 
percent of Iowa’s population in 2011, they accounted for 20 percent of the new HIV diagnoses. This 
equates to 26.9 diagnoses per 100,000 non‐Hispanic African-Americans. Hispanics were also 
overrepresented among persons diagnosed with HIV. While making up five percent of Iowa’s 
population, Hispanics accounted for 13 percent of new HIV diagnoses in 2011. A total of 15 Hispanics 
were diagnosed in 2011, equating to 9.9 per 100,000 Hispanics. While non-Hispanic Asians accounted 
for five percent of HIV diagnoses in 2011, their numbers are too small to calculate a statistically reliable 
rate. 
 
Despite the disparities in diagnoses among African Americans and Hispanics, the largest proportion of 
new diagnoses continued to be among white non‐Hispanics, accounting for 60 percent of new HIV 
diagnoses in 2011. A total of 72 white non‐Hispanics were diagnosed in 2011, equating to 2.7 per 
100,000 population. When the numbers of persons diagnosed per 100,000 population are compared, 
non‐Hispanic African Americans were 10 times more likely to have been diagnosed with HIV in 2011 
than white, non‐Hispanics. Similarly, Hispanics were 3.7 times more likely to have been diagnosed than 
white non‐Hispanics. Figure 10 shows the percent distribution of new HIV diagnoses by race and  
ethnicity.  
 
Men‐who‐have‐sex‐with‐men (MSM) 
remained the leading category for 
mode of exposure to HIV infection. 
Diagnoses among MSM in 2011 
numbered 66, compared to the five 
year average of 64 from 2006 to 2010. 
In 2011, MSM accounted for 55 
percent of all diagnoses, in line with 
the five‐year average of 55 percent. It 
is important to note that 18 (86 %) of 
the 21 diagnoses in young men 
between the ages of 15 and 24 were 
among MSM.  
 
Numbers (and proportions) of other modes of HIV exposure in 2011 were as follows: injection drug use 
(IDU), three (3%); men‐who‐have‐sex‐with-men and inject drugs (MSM/IDU), eight (seven %); 
heterosexual contact, 23 (19 %); and no identified risk (NIR), 19 (16 %). As noted, one infection was 
passed from mother to child during pregnancy or labor and delivery (such infections are termed 
“perinatal” or “vertical” transmission). 
 
 Seventy‐four persons were diagnosed with AIDS in 2011, similar to 73 in 2010 and down from 92 (the 
highest number since 1996) in 2009. The 74 diagnoses in 2011 are slightly fewer than the average of 76 
for the five years from 2006 through 2010. Of those diagnosed with AIDS in 2011, 40 (54%) were also 
newly diagnosed with HIV and had received a concurrent diagnosis of AIDS or progressed to AIDS by the 
end of 2011. This finding is more an indication of prevention failures than it is of treatment failure or 
access to care.  
 
HIV/AIDS prevalence continues to increase. As of December 31, 2011, there were 1,939 persons living 
with HIV or AIDS who were Iowa residents at the time of diagnosis of HIV or AIDS, a prevalence of 64 per 
100,000 people. This compares to 1,823 persons living with HIV/AIDS on the same date in 2010, a 
Figure 10. Percent distribution of HIV cases by race and ethnicity, 2011 
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prevalence of 60 per 100,000. Figure 11 depicts the upward trend in the estimated number of persons 
living with HIV or AIDS, as documented at the end of each calendar year. The top tier of the graph 
represents the estimated numbers of undiagnosed/unreported persons, based on the surveillance 
program’s estimate of the timeliness of case reporting and on CDC’s estimate of the number of persons 
who are infected but have not been diagnosed. When the number of 1,939 is adjusted for 
underreporting (1%) of diagnosed HIV and AIDS and for CDC’s estimated percentage of undiagnosed 
infections (20%), there may have been as many as 2,448 Iowans living with HIV or AIDS at the end of 
2011.  
Figure 11. Estimated number of persons living with HIV or AIDS in Iowa on December 31 of 
each year, 1987-2011 
 
 
Hepatitis C 
Hepatitis C is the most common chronic blood borne pathogen in the United States. According to the 
Centers for Disease Control and Prevention (CDC) there were an estimated 3.2 million people chronically 
infected with hepatitis C in the United States. According to the 2010 census population estimate for 
Iowa, there were 3,046,355 people residing in the state. CDC estimates that 1.8 percent of the state’s 
population, or 54,834 Iowans, has potentially been infected with the hepatitis C virus. To date, 
approximately 9,459 cases of hepatitis C have been identified by IDPH. 
 
Hepatitis C data are collected using IDSS, the state’s web‐based reporting system, to allow for collection 
of risk information, test results, referral information, and data on whether immunizations were offered.  
 
Sexually Transmitted Diseases 
The Bureau of HIV, STD, and Hepatitis is responsible for tracking the incidence of sexually transmitted 
diseases, including chlamydia, gonorrhea, and syphilis. In addition to disease surveillance, IDPH supports 
targeted voluntary screening at 68 public sites throughout Iowa. IDPH also works with private health 
care providers to increase screening. 
 
IDPH provides free treatment to individuals with positive STD tests at public testing sites. Sexual 
partners may be treated as well. In 2008, Iowa Code 139A was updated to allow for expedited partner 
therapy (EPT). This statute allows health care practitioners to give medications or prescriptions to their 
patients or to public health professionals to pass along to exposed partners, particularly when the 
partner is unable or unwilling to come in to a clinic for examination. 
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Chlamydia 
Genitourinary infections caused by Chlamydia trachomatis are extremely common in some populations. 
In fact, chlamydial infections account for the greatest number of cases of any reportable disease in the 
United States and in Iowa. Diagnoses of chlamydia have increased steadily during the past few decades. 
The reasons for this increase are varied. The most important reason is that testing technology has 
improved, allowing for more sensitive tests and more convenient ways to test. The use of nucleic acid 
amplification tests (NAATs) for the detection of Chlamydia trachomatis became widespread in Iowa in 
the mid-2000’s. This method of detection is much more sensitive than the previously used method of 
cell culture. NAATs also permit the use of a greater variety of specimen types. Urine and vaginal 
specimens (which can be collected much less invasively than the traditional specimen types of cervical 
and urethral) can be used for NAATs. Because most chlamydial infections cause no symptoms, there is a 
large pool of undiagnosed chlamydia in certain populations. As testing methodology has improved and 
as testing has increased, the number of cases reported has also increased.  
 
In 2011, 10,928 cases of chlamydia were reported to IDPH (Figure 12). This equates to 363 cases per 
100,000 population. Iowa is lower than the U.S. average of 426 cases per 100,000 population. Both 
nationally and in Iowa, adolescents and young adults are the most impacted populations. In Iowa, 88 
percent of reported infections occurred in persons 15 to 29 years of age. 
 
Figure 12. Number of cases of chlamydia and gonorrhea by year, 2000-2011 
 
 
Chlamydia also disproportionately 
affects people of color in Iowa 
(Figure 13). Although African-
Americans and other Black persons 
accounted for three percent of the 
population in Iowa, 19 percent of 
chlamydial infections were 
diagnosed in this population. In fact, 
according to national data from 
CDC6, Iowa ranks number one in the 
nation for the rate of chlamydia 
among the African-American/Black 
population in the US.
 
Figure 13. Chlamydia rates in Iowa by race, 2011 
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Gonorrhea 
Nationally, the number of reported cases of gonorrhea has remained fairly steady over the past decade. 
However, Iowa has experienced a gradual increase in the number of reported cases in recent years. 
NAATs have been utilized for gonorrhea as they have been for chlamydia. The most widely used tests 
incorporate gonorrhea and chlamydia testing into a single specimen collection. Thus, patients are 
typically tested for both infections simultaneously.  
 
In 2011, 1,966 cases of gonorrhea were reported to IDPH (Figure 12), which equates to 65 cases per 
100,000 population. This is well below the national average of 101 cases per 100,000 population. 
Gonorrhea has many similarities with chlamydia, chief of which is the population (i.e., 
adolescents/young adults) that it predominately affects. Eighty-one percent of reported cases in Iowa 
were among persons 15 to 29 years of age. African-Americans/Blacks are even more disproportionately 
affected by gonorrhea than they are by chlamydia in Iowa. Forty-four percent of reported cases were 
among African-Americans. Iowa also ranks number one for its rate of gonorrhea among African-
Americans in the US. 
 
Antimicrobial resistance is of continuing concern with Neisseria gonorrhoeae. The only class of 
antimicrobials still effective in the treatment of gonococcal infection is the cephalosporins. All other 
classes of antimicrobials possess insufficient efficacy to cure the infection on their own. Current 
guidelines recommend dual therapy of ceftriaxone with azithromycin or doxycycline7. Dual therapy is 
recommended because individuals infected with gonorrhea are often co-infected with chlamydia. 
Additionally, dual therapy may slow the development of resistance to cephalosporins. It is anticipated 
that N. gonorrhoeae will soon develop resistance to the cephalosporins, at which time treatment will 
become much more difficult. No new antimicrobials are available to treat gonorrhea. Researchers are 
investigating the use of drug combinations to cure gonococcal infections but their efficacies are 
unsubstantiated at this time. 
 
The significant disparities among African-Americans, the likelihood of further antimicrobial resistance by 
N. gonorrhoeae, and the steady number of cases make improving gonorrhea prevention a priority for 
IDPH and CDC. 
 
Syphilis 
Iowa is a low-morbidity state for syphilis. In 2011, only 70 cases of syphilis were reported to IDPH, a rate 
of 2 per 100,000 population. This is less than half the U.S. average of 4.4 per 100,000 population. The 
preponderance of syphilis cases occurred in men, accounting for 66 percent of reported cases in 2011. 
Of these, the majority were men who have sex with men (MSM). Co-infection with HIV is a concern with 
this population, so concurrent testing for HIV is recommended for persons at risk for syphilis. 
 
African-Americans in Iowa are disproportionately 
affected by syphilis. Twenty-nine percent of 
reported cases were among this population, 
equating to a rate of 22 cases per 100,000 
population.
Elimination of syphilis from Iowa has proven 
difficult due to sporadic clusters of cases and the 
spread from other states. However, it is the goal 
of IDPH to follow up on every case of syphilis in 
Iowa and to offer treatment and partner services.
  Figure 14. Number of cases of syphilis by year 2000-2011 
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Summary of enteric diseases 
 
Campylobacteriosis 
The total number of campylobacteriosis cases reported in 2011 was 747. Campylobacteriosis incidence 
was 24.5 cases for every 100,000 people in 2011.  
 
Campylobacteriosis activity typically peaks in early summer. Consumption of raw, undercooked meat, 
raw milk, contaminated water, and contact with infected animals are common sources of campylobacter 
infection. In 2011, IDPH interviewed all reported people with Campylobacter and those people who 
were epidemiologically linked in an attempt to identify clusters. No clusters were identified, but the 
interview information was helpful to assess risk factors for Campylobacteriosis. 
 
Figure 15. Campylobacteriosis cases versus 5 year average by month and year, 2009-2011 
 
 
Cryptosporidiosis 
Cryptosporidiosis activity in 2011 decreased over activity in 2010. There were 11.9 cases for every 
100,000 Iowans in 2011, compared to 13.2 in 2010. Most cases reported either child care attendance or 
recreational water exposure. One outbreak was investigated that involved animal contact at a day camp.  
 
Figure 16. Cryptosporidiosis cases versus 5 year average by month and year, 2009-2011 
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E. coli O157:H7 and other shiga-toxin producing strains 
The incidence of E. coli shiga-toxin cases in Iowa increased slightly to 6.2 cases per 100,000 persons in 
2011 from 5.8 cases per 100,000 persons in 2010. There were 189 cases reported in 2011. IDPH assisted 
in a national outbreak investigation involving romaine lettuce and one state outbreak associated with a 
meal served in a private home in 2011.  
 
Figure 17. E. coli O157:H7 and other shiga-toxin producing strains cases versus 5 year average by 
month and year, 2009-2011 
 
 
Giardiasis 
Giardiasis is one of the leading waterborne diseases. It typically peaks in late summer or early fall. 
In 2011, there were 271 cases in Iowa. Diapered children and those in child care are most likely to 
become infected with giardia. Twenty-one percent of cases were age five and under. There were 8.9 
cases for every 100,000 Iowans compared to 9.4 per 100,000 in the previous year.  
 
Figure 18. Giardiasis cases versus 5 year average by month and year, 2009-2011 
 
 
Hepatitis A 
In 2011, there were eight cases of hepatitis A reported in Iowa. This represents an 81 percent reduction 
over the previous three year average of 41, most likely due to increases in vaccination. Cases ranged 
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from 20 to 69 years of age, with only one case younger than 25. Seventy-five percent of cases were 
males. None of the illnesses were associated with outbreaks. 
 
Figure 19. Hepatitis A cases versus 5 year average by month and year, 2009-2011 
 
 
Listeriosis 
There were five cases of Listeria monocytogenes infections reported in 2011. One case was associated 
with a national Listeria outbreak involving cantaloupes.  
 
Salmonellosis 
Salmonellosis incidence in 2011 decreased to 14.7 cases per 100,000 persons from 17.6 cases per 
100,000 persons in 2010. The total number of cases reported was 448. IDPH participated in two national 
outbreaks, one associated with ground turkey; the other with a major chain restaurant. A statewide 
outbreak involving baby chicks was also investigated. 
 
Figure20. Salmonellosis cases versus 5 year average by month and year, 2009-2011 
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  Shigellosis 
In 2011, there were 18 cases of Shigella in Iowa. This was an approximate 83 percent decrease over the 
average number of cases for the past three years. Shigella infections were reported in all areas of the 
state. Approximately 39 percent of cases were under five years old; approximately 39 percent in persons 
aged 24-64 years. This corresponds to children and their parents or caretakers being at most risk. 
 
 Figure 21. Shigellosis cases versus 5 year average by month and year, 2009-2011 
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Summary of zoonotic diseases
Dengue fever 
In 2011, five cases of Dengue fever were reported to IDPH, an increase of three from the cases reported 
in 2010. Of the five cases, two were female and three were male. Four were with international travel to 
countries where the Dengue virus is endemic and one with location acquired unknown.  
 
Ehrlichiosis/Anaplasmosis 
There are at least three species of bacteria responsible for ehrlichiosis/anaplasmosis in the United 
States: Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Ehrlichia ewingii. The clinical signs of 
disease that result from infection with these agents are similar. 
In 2011, there were eight cases of ehrlichiosis/anaplasmosis reported to IDPH, an increase of six from 
the cases reported in 2010. Median age of the cases was 59 years.  
Hantavirus 
There was one report of hantavirus pulmonary syndrome (HPS) case in Iowa in 2011. There have been 
eight cases of HPS reported in Iowa since the disease was first identified in 1993. Substantial rodent 
exposure was identified in most cases. 
 
Lyme disease 
Lyme disease is caused by the bacterium Borrelia burgdorferi and is transmitted to humans by the bite of 
an infected tick, primarily the blacklegged tick. Symptoms of Lyme disease include fever, headache, 
fatigue, and a “bull’s-eye” skin rash also known as erythema migrans. There were 100 cases of Lyme 
disease reported to IDPH in 2011. The 2011 Iowa case rate for Lyme disease was 3.3 per 100,000. Cases 
ranged from ages two to 89. 
 
Figure 22. Confirmed and probable cases of Lyme disease reported to IDPH, 2000-2011 
 
 
Malaria 
Twenty-two cases of malaria were identified in Iowa in 2011, an increase of eight from the 14 cases 
reported in 2010; 19 patients acquired their infections outside the US and three cases had no 
information on location acquired for their infections.  
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Rabies, Animal 
In 2011, 25 cases of animal rabies were reported in Iowa, which is a slight decrease from 2010 (Table 4). 
Rabies was identified most frequently in wildlife species including 12 bats and 7 skunks. Three cases 
were diagnosed in cats; three cows also tested positive.  
 
During 2011, 1,493 animals in Iowa were tested for 
rabies and 25 were confirmed positive (1.7 %). The 
percent positive varies greatly by species (Table 3). 
It is important to note that these data are greatly 
influenced by the number of animals tested and 
typically only animals that have exposed humans 
are tested. Many animals are tested because they 
exhibit unusual behavior or clinical signs making them more likely to be infected with the rabies virus. 
For these reasons, the percentages should not be considered representative of the true distribution of 
disease within the animal population in Iowa.  
 
There are two rabies strains that commonly circulate in Iowa (bat and skunk), and many different 
species can be infected with these strains. In animal samples that are strongly positive for rabies (the 
strain typing procedure is only effective in samples that are strongly positive), SHL can differentiate the 
rabies strain that infected the animal. In 2011, SHL was able to identify the rabies strain in 22 of the 25 
positive rabies cases; 11 were skunk strain and 11 were bat strain. Skunk strain rabies was identified in 
seven skunks, three cows, and one cat. Bat strain rabies was identified in 10 bats and one cat. For more 
information about rabies, visit  
www.idph.state.ia.us/Cade/DiseaseIndex.aspx?disease=Rabies 
 
Table 4. Number of animals positive for rabies by species and by year, 2001-2011 
Species 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Bat 31 27 47 47 60 28 13 11 11 10 12 
Skunk 28 27 38 28 33 13 5 7 13 13 7 
Cat 10 7 8 11 5 7 7 9 3 1 3 
Cow 10 12 3 10 7 4 0 1 5 1 3 
Dog 2 3 6 3 2 2 5 1 2 1 0 
Horse 3 2 3 0 1 3 1 0 0 0 0 
Fox 1 0 0 1 0 0 0 0 0 1 0 
Squirrel 0 0 0 0 0 0 0 0 1 0 0 
Badger 0 0 1 0 0 0 0 0 0 0 0 
Total 85 78 106 100 108 57 31 29 35 27 25 
 
Rabies, Human 
Iowa’s most recent human rabies case occurred in 2002, and was caused by the bat strain. Prior to that, 
the last reported human case occurred in 1951.  
  
While the exact number of people who receive rabies post-exposure prophylaxis each year in the United 
States is unknown, it is estimated to be about 40,000 people. Based upon Iowa’s population, it is 
estimated that approximately 390 Iowans receive preventive treatment each year.  
 
Rocky Mountain Spotted Fever (RMSF) 
In 2011, there were seven cases of Rocky Mountain spotted fever (RMSF) reported in Iowa. American 
dog ticks are carriers of Rickettsia rickettsii, the bacterium that causes RMSF. The American dog tick is 
Table 3. Number of animals positive for rabies 
virus by species, 2011 
Species Positive Total Tested % Positive 
Cow 3 67 4.48% 
Cat 3 369 0.81% 
Bat 12 506 2.37% 
Skunk 7 22 31.82% 
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the most common species of tick in Iowa and can be found in every county in the state. The tick is most 
active late March through August. Iowa RMSF cases in 2011 had symptom onset dates from February to 
November. Cases ranged from age 9 to 81, with a median age of 35. Five cases are male and two female. 
 
West Nile Virus 
There were nine human cases of West Nile virus reported to IDPH in 2011. Five of the nine cases were 
hospitalized, and all survived this illness. Cases ranged from age 29 to 73, with a median age of 55. 
Seven cases were male and two were female. For more information about this disease, visit 
www.idph.state.ia.us/CADE/DiseaseIndex.aspx?disease=West Nile Virus 
Table 5. Iowa West Nile virus activity by species and outcome, 2002-2011 
  2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Human cases 54 147 23 37 37 30 5 5 9 9 
Human deaths 2 6 2 2 0 3 1 0 2 0 
Sentinel chickens 31 15 9 19 18 18 3 6 14 14 
Mosquito pools 8 27 0 7 15 5 5 9 7 5 
Horses 1142 96 18 15 12 10 4 3 2 1 
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Summary of Rare and Unusual Diseases 
 
Legionellosis  
The average number of Legionella cases for the past three years is 20 cases. There were 11 cases of 
legionellosis reported to IDPH in 2011. Of these cases, 10 were hospitalized and one died from the 
disease. 
 
Toxic Shock Syndrome 
There was one case of Toxic Shock Syndrome reported to IDPH in 2011, which occurred in a 19 year-old 
female.    
 
Tularemia 
There were three cases of tularemia reported to IDPH in 2011. Two cases were male and one, female. 
Age ranged from 34 to 68 with a median age of 59 years.  
 
There were no cases of human illness reported for the following diseases: 
Hansen’s disease (Leprosy) 
Hepatitis E 
Psittacosis 
Tetanus 
Yellow Fever 
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Summary of environmental health conditions 
 
Carbon Monoxide (CO) Poisoning Surveillance 
Each year, according to the CDC, more than 400 Americans die from unintentional CO poisoning; 
additionally more than 20,000 visit the emergency room, and more than 4,000 are hospitalized due to 
CO poisoning. Fatalities are highest among Americans 65 and older. IDPH collects reports of CO 
poisoning and CO exposure from health care providers and facilities, and the Iowa Statewide Poison 
Control Center. CO poisoning is defined in Iowa as: 
 A blood carbon monoxide level equal to or greater than 10 percent carboxyhemoglobin or its 
equivalent with a breath analyzer test or;  
 A clinical diagnosis of carbon monoxide poisoning regardless of any test result.  
Information collected includes basic demographics (age, gender, county of residence), diagnosis, blood 
carboxyhemoglobin test results, exposure (circumstance, source, location), and severity of health 
impact. Reports are reviewed to identify clusters and possible occupational exposures for further  
investigation and intervention. 
 
In 2011 there was one reported death from CO 
exposure in Iowa. Seventy-four individual 
reports of CO exposure were received by IDPH. 
Fifty of these reports met the case definition for 
carbon monoxide poisoning. 
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Fatal – Patient died due to Carbon monoxide poisoning 
Moderate – Patient experienced moderate symptoms such as 
nausea, vomiting, confusion 
Minor – Patient experienced minor symptoms such as headache, 
dizziness 
No Effect – Patient experienced no symptoms consistent with CO 
exposure 
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Vehicles include automobiles and other fuel-powered recreational 
vehicles (e.g., boats, four-wheelers, Zamboni). 
Fixed appliances include fuel-burning equipment that is typically 
stationary (e.g., furnaces, gas water heaters, gas stoves or 
fireplaces). 
Mobile appliances include generators, space heaters, and other 
small power equipment (e.g., power washers, lawn mowers, 
chainsaws). 
 
 
 
 
 
Table 6. Gender of cases with carbon monoxide 
poisoning meeting case definition, 2011 
 Number of cases 
Male 32 
Female 15 
Total 50* 
*Gender was not specified for 3 cases. 
 
Figure 24. Sources of exposure among case patients 
with CO poisoning, 2011  
 
Figure 23. Severity of health impact among case 
patients with CO poisoning, 2011 
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Methemoglobinemia 
Methemoglobinemia is a blood disorder caused when nitrite interacts with the hemoglobin in red blood 
cells, reducing the ability to carry sufficient oxygen to individual body cells. Infants under six months of 
age are the primary population at risk, and the condition is also known as ‘Blue Baby Syndrome.’ Sources 
of nitrite include nitrate in drinking water or from preservatives in food, some drugs, or other sources. 
 
In 2011 there were five cases of methemoglobinemia reported in Iowa. None of the cases were infants. 
 
Heavy Metal Poisoning (Non-Lead) 
IDPH conducts surveillance for three other heavy metals in addition to lead; arsenic, cadmium, and 
mercury. Cases of poisoning from these three heavy metals are rare in Iowa, and many exposures are 
related to industrial or hobby/small market work in industries that use these metals. Outside of 
industrial use, the possibility of arsenic contamination of moonshine, herbal preparations, and 
nutritional supplements also must be considered as a source of exposure. Other potential sources of 
mercury exposure include consumption of large amounts of contaminated fish and seafood; or from 
broken thermometers, barometers, fluorescent light bulbs, or electrical switches. In 2011, there were 
eight cases of mercury poisoning and no cases of arsenic and cadmium poisoning reported. 
 
Childhood lead poisoning 
 Lead has adverse effects on nearly all organ systems in the body. It is especially harmful to the 
developing brains and nervous systems of children under the age of six. At very high blood lead levels, 
children can have severe brain damage or even die. At blood lead levels as low as 10 micrograms per 
deciliter (μg/dL), children’s intelligence, hearing, and growth are affected. This damage can be 
minimized if a child’s lead exposure is reduced. However, the damage cannot be reversed. A child is 
considered to be lead‐poisoned at a blood lead level of 10 μg/dL or higher. 
 
In 2002, researchers estimated that the average decrease in lifetime earnings of a child with a blood 
lead level of10 μg/dL would be at least $40,000 and that the average decrease for a child with a blood 
lead level of20 μg/dL would be at least $80,000. 
 
Iowa's children are most commonly poisoned by lead‐based paint found in homes built before 1950. 
Lead‐based paint in a home becomes a lead hazard as it deteriorates and lead‐based paint chips end up 
on the floors and in window wells throughout the home, as well as in the soil around the exterior of a 
home. Since 1992, IDPH has recommended that all children under the age of six be tested for lead 
poisoning through a blood test and has also has required the results of all blood lead testing to be 
reported to IDPH. State and federal laws mandate lead testing for children receiving Medicaid. Since 
2008, Iowa law has required that all children have proof of a blood lead test when enrolling in 
kindergarten. 
 
IDPH reports the rate of blood lead testing among children and the prevalence of lead poisoning by birth 
cohort (a group of children born during a specific year). IDPH has complete data for children born in 
1991 through 2005. During that time, the percentage of children tested for lead poisoning has increased 
from 26 percent to 97.9 percent.  
 
In Iowa, the prevalence of lead poisoning among children under the age of six is 3.2 percent. At the 
national level, the prevalence of blood lead levels greater than or equal to 10 µg/dL is too small to 
report. Data collected by IDPH include the number and percentage of children born in 2005 who were 
tested for lead poisoning, the number and percentage of all children tested who were identified as 
lead‐poisoned as well as the number and percentage of children who were tested for lead poisoning and 
identified as lead‐poisoned by Medicaid status (see Table 15). 
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ADULT LEAD POISONING 
A total of 5,690 blood lead test (BLL) results on 3,155 Iowans were recorded by the Iowa Adult Blood 
Lead Epidemiology and Surveillance (ABLES) program for adults 16 years or older with a residence in 
Iowa tested in calendar year 2011 (Table 16 for data by county) . All blood lead test results for Iowa 
residents are reportable to IDPH under Iowa Administrative Code 641, Chapter 1.  
 
Blood lead tests of 10 micrograms per deciliter (µg/dL) or higher are currently defined as an elevated 
blood lead level (EBL). Based on the highest BLL for each person tested in 2011, there were 832 people 
(26.4 percent of those tested) who had blood lead levels of 10 µg/dL or higher:  37 people with levels 40 
µg/dL or higher, 203 people with levels 25-39 µg/dL, and 592 people with levels 10-24 µg/dL.  
 
Of the 832 adults with EBLs, 247 (29.8 %) were classified as new cases; that is, they did not have a blood 
lead levels of 10 µg/dL or higher in the 2010 records in the Iowa ABLES database. The average blood lead 
level for new cases was 22 µg/dL with a range of 10-94 µg/dL. Of the new cases, 172 were known to be 
work-related exposures, and 159 of 247 (64 %) were classified by their occupational industry. The lead 
battery manufacturing industry accounted for 114 (46 %) of the new cases.  
 
New cases included a cluster of elevated blood lead levels were identified linked to usage of ayurvedic 
products obtained from India by people pursuing alternative medicine practices. A total of 123 people 
known to be using ayurvedic products had blood lead test results reported in the 2011 Iowa data. 
Ayurvedic medicine ingestion accounted for 44 (18 %) of the new cases. Firearms-related hobbies or 
exposure were identified as the lead source for eight (three %) of the new cases in 2011.  
 
For the 582 adults with an EBL in 2011 who had a prior EBL in 2010, all but five had known work-related 
lead exposure. This group’s 2011 EBLs ranged from 10 - 47 µg/dL with an average BLL of 21, and 168 had 
EBLs of 25 µg/dL or higher. 
 
Females accounted for 11.4 percent (95) of the 832 EBLs in 2011, with an average blood lead level of 22 
µg/dL, which was an increase from 2010 (2010 N=78, average BLL=18 µg/dL). The blood lead levels for 
EBL females ranged from 10-69 µg/dL. Lead exposure to women during pregnancy poses increased 
health risks for unborn babies and may impact the ability to carry the pregnancy to term.  Women of 
child-bearing age (16-44 years of age i.e. those born in 1966 or later) accounted for 25 of the 95 female 
cases (26 %), and 10 of the 95 EBLs females (10.5 %) were 35 years of age or younger. It is unknown if 
any of these women were pregnant at the time of their exposure. Most of the females with EBLs (74 of 
95, 78 %) had work-related exposure to lead, with 66 of 74 (89 %) working in the lead battery 
manufacturing industry and 60 of the 95 females (63 %) having an elevated blood lead in both 2010 and 
2011. Ayurvedic product usage was known to be the route of exposure for 17 of the EBL women (18 %), 
and none of them had a prior blood lead level on record for 2010.  
 
Iowa’s high risk industries in 2011 remain consistent with data from previous years, with the majority 
(695/832 or 84%) of EBL adults working in manufacturing plants that use lead or metal products that 
contain lead. Seven employers accounted for 688 workers with EBLs or almost 83 percent of the 832 
Iowans with elevated blood test results for 2011. These workers are also the most likely to be tested for 
lead exposure because of regulatory oversight or concerns about the risk of exposure. Other work-
related cases in 2011 include worker exposures from indoor firing ranges, recyclable materials 
wholesalers, automotive or radiator repair, leaded glass workers, and workers in the construction or 
remodeling industry. Additional workers – especially those working for smaller companies or those who 
are self-employed - may have lead exposure but were never tested during the year.  
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Table 7. Iowa adult blood lead test results, 2009-2011 and changes from 2010-2011 
 Number of Iowa Adults 
Tested by Highest 
BLL/Year 
 Percent of all Iowa Adults 
Tested by BLL Range for Year 
IA ABLES DATA 2011 2010 2009 
2011 change in numbers 
from 2010 
2011 2010 2009 
BLL 40 µg/dL or higher 37 14 13 +23 1.1% 0.5% 0.5% 
BLL 25-39 µg/dL 203 159 172 +44 6.5% 5.5% 7.2% 
BLL 10-24 µg/dL 592 563 509 +29 18.8% 19.4% 21.2% 
BLL 0-9 µg/dL 2323 2169 1711 +154 73.6% 74.7% 71.1% 
All BLL 10+ (Total EBLS) 832 736 694 +96 26.4% 25.3% 28.9% 
Total Individuals Tested  3155 2905 2405 +250    
Adults:  Persons 16 years of age or older as of the date of blood test. 
Iowa Adult Data:  Test results for persons with an Iowa residential address as of the date of blood test. Blood lead test reports received without 
address data or with a residential address outside of Iowa are not included in this report. The report reflects data in the database as of May 23, 
2012. Later data entries are not included at this time. 
 
TRAUMATIC WORK-RELATED FATALITIES SURVEILLANCE  
The IDPH Occupational Health and Safety Surveillance Program (OHSSP) includes the Iowa Fatality 
Assessment and Control Evaluation (FACE) program, which is subcontracted to the University of Iowa 
College of Public Health Injury Prevention Research Center (UI IPRC). The program is a collaboration 
between the OHSSP, the Iowa Office of the State Medical Examiner, and UI IPRC through funding 
provided by the National Institute of Occupational Safety and Health (NIOSH). Iowa FACE has identified 
90 work‐related fatalities for 2011 (preliminary data), which is above the 10‐year average of 80 cases 
(2001-2010). Transportation incidents of all types are the largest single event causing work‐related 
fatalities in Iowa (46/90, 51%) including 27 roadway fatalities, 16 off-roadway fatalities, and three 
involving rail or plane fatalities. Agriculturally (ag)-related activities involved 32 of the 90 deaths (35%), 
including 20 of the transportation incidents. Of the 20 ag-related transportation incidents, 14 occurred 
off-roadway. Ages for work-related fatalities ranged from 10 to 85 years of age. Females accounted for 
11 (12%) of the work-related deaths.  
 
For fatalities to be included as a FACE “case”, the 
incident causing the work‐related death has to occur 
in Iowa (resident or non‐resident), and be traumatic 
in nature. Cases include work-related deaths of 
persons regardless of compensation status, that is, 
volunteers or family members who are working 
regardless of payment. Deaths that occur while 
commuting to or from work do not qualify. Iowa 
workers killed while working out of state are not 
included. 
 
Some potential cases may not be identified due to 
lack of surveillance data, especially for individuals killed in motor vehicle crashes when it is unknown 
that the person was traveling as part of their job duties (other than commuting). For this reason, some 
cases are not identified until months after the 
incident. For these reasons total case numbers may differ between those reported by other programs, 
such as the US Bureau of Labor Statistics Census of Fatal Occupational Injuries (CFOI) or the Iowa Worker 
Memorial Day observance. Additional information can be found at www.public-health.uiowa.edu/face/
Figure 25. Iowa FACE work-related death, 2001-2011    
 
* Updated data 
**Preliminary data 
 
* Updated data    **Preliminary data 
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2011 Iowa summary of reported outbreak investigations  
Table 8. Foodborne outbreaks 
Type Nature 
of  Episode 
Event/Place Location of 
Food 
Preparation 
Location of 
Food 
Consumption 
Region Month Number 
Affected/Number 
Exposed (if known) 
Food Vehicle of 
Transmission 
Agent Involved 
Foodborne 
 
Diarrhea, 
Nausea, 
Fever 
Restaurant Restaurant Restaurant 1 April 12/18 Unknown Clostridium 
species 
Foodborne 
 
Diarrhea, 
Vomiting, 
Nausea 
Shooting 
Competition 
Home Outside 1 June 12/100 Unknown Unknown,  
suspected toxin  
Foodborne 
 
Diarrhea, 
Vomiting, 
Nausea 
Potluck Home Home 1 July 10/100 Unknown E.coli O157:H7 
Foodborne 
(National 
Outbreak) 
Diarrhea, 
Vomiting, 
Nausea 
Home Home Home Multi-
county 
June 2 Ground Turkey Salmonella 
Heidelberg 
Foodborne 
(National 
Outbreak) 
Fever, 
Headache, 
Vomiting, 
Nausea 
Home Home Home 3 September 1 Cantaloupe Listeria 
monocytogenes 
Foodborne 
 
Diarrhea, 
Vomiting, 
Nausea 
Church Church Church 1 October 2, 1 epi-link Unknown Salmonella 
Lagos 
Foodborne 
(National 
Outbreak) 
Bloody Diarrhea, 
Abdominal 
Cramps 
Restaurant Restaurant Restaurant 1 October 1 Unknown Salmonella 
Enteriditis 
 
Foodborne 
(National 
Outbreak) 
Bloody Diarrhea, 
Vomiting, 
Abdominal 
Cramps 
College College College 6 November 1 Romaine 
Lettuce 
E.coli O157:H7 
 
Foodborne Diarrhea, 
Vomiting, 
Abdominal 
Cramps 
Workplace Home Workplace 6 December 21 Unknown Clostridium 
perfringens 
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Table 9. Non-foodborne or unknown cause outbreaks  
Type Nature of  Episode Event/Place Region Month Number 
Affected/Number 
Exposed (if known) 
Vehicle of 
Transmission 
Agent Involved, 
Number of  Positive 
Tests, if known 
Person-to-Person 
 
Diarrhea, Vomiting Restaurant 4 January 7/9 Person-to-Person Norovirus – 3 
Person-to-Person 
 
Diarrhea, 
Abdominal Cramps 
Assisted Living/Long 
Term Care Facility 
4 January 18/25 Person-to-Person Norovirus - 2 
Person-to-Person 
 
Headaches, 
Diarrhea, Vomiting, 
Doctors Office 4 January 17 Person-to-Person Unknown 
Vaccine Preventable Fever, Cough Long Term Care 
Facility 
3 January 6 Person-to-Person Influenza A H3 -3 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps, Fever 
Clinic 3 January 20 Person-to-Person Norovirus - 2 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps, Fever 
Long Term Care 
Facility 
1 January 19 Person-to-Person Norovirus - 3 
Person-to-Person 
 
Diarrhea, Vomiting, 
Nausea 
Long Term Care 
Facility 
1 February 16 Person-to-Person Norovirus - 1 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps, 
Nausea 
Restaurant 1 February 6 Person-to-Person Norovirus - 2 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps, Fever 
School 4 February 34 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Nausea 
Long Term Care 
Facility 
1 March 10 Person-to-Person Norovirus - 3 
Vaccine Preventable Vomiting, Fever, Cough Long Term Care 
Facility 
6 March 9 Vaccine Preventable Suspect Influenza 
Person-to-Person 
 
Diarrhea, Vomiting, 
Nausea, Fever, Abdominal 
Cramps 
Childcare Center 3 March 16 Person-to-Person Rotavirus - 2 
Person-to-Person 
 
Diarrhea, Vomiting, 
Nausea, Abdominal 
Cramps 
Restaurant 1 March 4 Person-to-Person Suspect Norovirus 
Animal Contact 
 
Diarrhea, Nausea, 
Abdominal Cramps 
Children’s Event 5 April 20 Animal Contact 
 
Cryptosporidium 
Person-to-Person 
 
Diarrhea, 
Abdominal Cramps 
Restaurant 1 April 12 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, 
Abdominal Cramps 
Long Term Care 
Facility 
1 April 25 Person-to-Person Norovirus - 4 
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Animal-to-Person 
 
Diarrhea, 
Abdominal Cramps 
Farm Supply Store Multi-
county 
April 5 Animal-to-Person Salmonella Berta 
Person-to-Person 
 
Diarrhea, 
Vomiting 
Long-Term Care 
Facility 
6 June 20 Person-to-Person Norovirus - 3 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Home 6 October 14 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 1 October 4 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 1 November 5 Person-to-Person Norovirus - 2 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Carry-out Meal 4 November 7 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Long-Term Care 
Facility 
6 November 17 Person-to-Person Norovirus - 3 
Person-to-Person 
 
Diarrhea, 
Vomiting 
School 4 November 66 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 4 November 7 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 1 November 6 Person-to-Person Norovirus -2 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Assisted Living Facility 6 December 24 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 6 December 7 Person-to-Person Norovirus -1 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
School 2 December 13 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 6 December 26 Person-to-Person Suspect Norovirus 
Person-to-Person 
 
Diarrhea, Vomiting, 
Abdominal Cramps 
Restaurant 1 December 4 Person-to-Person Suspect Norovirus 
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Table 10. Cases and rates per 100,000 population for 2011 by age group 
 
0 to 4 5 to 19 20 to 29 30 to 39 40 to 64 >64 Unk Total 
Disease 
Case
s Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnoses) 0 0.0 0 0.0 15 3.6 18 5.0 40 4.0 1 0.2 0 74 2.4 
Botulism 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 0 0.0 
Campylobacteriosis 101 50.0 130 21.0 96 23.3 76 21.0 248 24.8 96 21.2 0 747 24.5 
Chlamydia 12 5.9 2973 480.8 6634 1613.4 1083 299.3 222 22.2 4 0.9 0 10928 358.7 
  Cryptosporidiosis 54 26.7 78 12.6 51 12.4 48 13.3 73 7.3 60 13.2 0 364 11.9 
Dengue fever 0 0.0 0 0.0 1 0.2 1 0.3 2 0.2 1 0.2 0 5 0.2 
E. coli/other shgt producing 31 15.3 67 10.8 22 5.4 11 3.0 30 3.0 28 6.2 0 189 6.2 
Ehrlichiosis/anaplasmsis 0 0.0 0 0.0 0 0.0 1 0.3 4 0.4 3 0.7 0 8 0.3 
Giardiasis 56 27.7 41 6.6 34 8.3 33 9.1 85 8.5 22 4.9 0 271 8.9 
Gonorrhea 0 0.0 494 79.9 1115 271.2 265 73.2 92 9.2 0 0.0 0 1966 64.5 
Hemolytic uremic syndrome 7 3.5 4 0.6 1 0.2 0 0.0 0 0.0 1 0.2 0 13 0.4 
Hepatitis A 0 0.0 0 0.0 1 0.2 2 0.6 4 0.4 1 0.2 0 8 0.3 
Hepatitis B, acute 0 0.0 0 0.0 3 0.7 5 1.4 6 0.6 1 0.2 0 15 0.5 
Hepatitis B, chronic 0 0.0 7 1.1 46 11.2 56 15.5 63 6.3 10 2.2 0 182 6.0 
HIV (diagnoses) 1 0.5 2 0.3 44 10.7 29 8.0 42 4.2 2 0.4 0 120 3.9 
Legionellosis 0 0.0 0 0.0 1 0.2 0 0.0 3 0.3 7 1.5 0 11 0.4 
listeriosis 0 0.0 0 0.0 1 0.2 0 0.0 1 0.1 3 0.7 0 5 0.2 
Lyme disease 6 3.0 25 4.0 14 3.4 9 2.5 31 3.1 15 3.3 0 100 3.3 
Malaria 0 0.0 3 0.5 15 3.6 2 0.6 1 0.1 1 0.2 0 22 0.7 
Meningococcal Inv. Disease 2 1.0 1 0.2 1 0.2 0 0.0 4 0.4 6 1.3 0 14 0.5 
Mumps 0 0.0 2 0.3 4 1.0 0 0.0 2 0.2 0 0.0 0 8 0.3 
Pertussis (whooping cough) 68 33.6 100 16.2 16 3.9 20 5.5 25 2.5 3 0.7 0 232 7.6 
Q fever 1 0.5 0 0.0 0 0.0 0 0.0 0 0.0 1 0.2 0 2 0.1 
Rocky Mountain spotted fever 0 0.0 1 0.2 2 0.5 1 0.3 1 0.1 2 0.4 0 7 0.2 
  Salmonellosis 69 34.1 79 12.8 60 14.6 46 12.7 130 13.0 64 14.1 0 448 14.7 
  Shigellosis 6 3.0 4 0.6 1 0.2 3 0.8 2 0.2 2 0.4 0 18 0.6 
Syphilis 3 1.5 4 0.6 23 5.6 20 5.5 19 1.9 1 0.2 0 70 2.3 
Tuberculosis 0 0.0 4 0.6 9 2.2 10 2.8 10 1.0 7 1.5 0 40 1.3 
Typhoid fever 0 0.0 0 0.0 1 0.2 1 0.3 1 0.1 1 0.2 0 4 0.1 
West Nile virus   0 0.0 0 0.0 1 0.2 1 0.3 4 0.4 3 0.7 0 9 0.3 
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Table 11. Cases and rates per 100,000 population for 2011 by sex, Iowa 
  Sex 
 
Female Male Unk Total 
Disease Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnosis) 8 0.5 66 4.4 0 74 2.4 
Botulism 0 0.0 0 0.0 0 0 0.0 
Campylobacteriosis 323 21.0 424 28.1 0 747 24.5 
Chlamydia 7813 508.0 3115 206.5 0 10928 358.7 
Cryptosporidiosis 194 12.6 170 11.3 0 364 11.9 
Dengue fever 2 0.1 3 0.2 0 5 0.2 
E. coli and other shiga-toxin producing  110 7.2 79 5.2 0 189 6.2 
Ehrlichiosis/anaplasmsis  4 0.3 4 0.3 0 8 0.3 
Giardiasis 118 7.7 152 10.1 1 271 8.9 
Gonorrhea 1245 80.9 721 47.8 0 1966 64.5 
Hemolytic uremic syndrome 7 0.5 6 0.4 0 13 0.4 
Hepatitis A 2 0.1 6 0.4 0 8 0.3 
Hepatitis B, acute 2 0.1 13 0.9 0 15 0.5 
Hepatitis B, chronic 70 4.6 112 7.4 0 182 6.0 
HIV (diagnoses) 20 1.3 100 6.6 0 120 3.9 
Legionellosis 3 0.2 8 0.5 0 11 0.4 
Listeriosis 4 0.3 1 0.1 0 5 0.2 
Lyme disease 38 2.5 62 4.1 0 100 3.3 
Malaria 3 0.2 19 1.3 0 22 0.7 
Meningococcal invasive disease 6 0.4 8 0.5 0 14 0.5 
Mumps 2 0.1 6 0.4 0 8 0.3 
Pertussis (whooping cough) 130 8.5 102 6.8 0 232 7.6 
Q fever 1 0.1 1 0.1 0 2 0.1 
Rocky Mountain spotted fever 2 0.1 5 0.3 0 7 0.2 
Salmonellosis 229 14.9 219 14.5 0 448 14.7 
Shigellosis 10 0.7 8 0.5 0 18 0.6 
Syphilis 24 1.6 46 3.0 0 70 2.3 
Tuberculosis 11 0.7 29 1.9 0 40 1.3 
Typhoid fever 2 0.1 2 0.1 0 4 0.1 
West Nile virus 2 0.1 7 0.5 0 9 0.3 
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Table 12. Notifiable diseases by year, 1991-2011 
Notifiable 
diseases 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
AIDS (diagnosis) 117 157 103 110 104 97 75 60 77 80 80 75 75 70 78 79 68 66 92 73 74 
Anthrax                                           
  Botulism                 1         1   1 1 1 0     
  Brucellosis  1 1 2 1 2 4 4 1 6   2 1     1 2 0 2 2   1 
Campylobacteriosis 333 260 292 280 274 339 425 455 467 499 467 427 458 559 537 449 524 591 552 751 747 
Chlamydia   6125 5214 5412 5088 4165 4906 5173 5511 5989 5716 6241 6462 6958 7390 8399 8643 9372 9406 10542 10928 
Cholera       1         1                         
  Cryptosporidiosis       71 21 75 71 66 56 77 82 49 122 90 122 230 610 284 232 397 364 
  Cyclospora           3 1 3     1               1   1 
  Dengue Fever                             1 1 6 5 2 2 5 
 Diphtheria                                           
  Ehrlichiosis                       1 1   4 7 7 7 8 2 8 
  Encephalitis 
(arboviral except 
WNV) 4 3 4 1 13 19 3 3 3 4 3 3   2   1           
E. coli/other shiga-
toxin producing 15 20 27 54 64 123 114 93 114 180 81 122 103 124 108 161 185 208 163 173 189 
Hemolytic uremic 
syndrome*                     13 
  Giardiasis 422 351 340 339 391 410 358 429 377 420 345 315 277 301 280 302 301 326 291 284 271 
Gonorrhea   1653 1824 1645 1723 1144 1309 1615 1365 1394 1424 1496 1544 1249 1606 1981 1928 1700 1658 1804 1966 
  Haemophilus 
influenzae Type B 15 7 5 6 3 4 6 5 2         1   2 1 2 1 1 3 
  Hansen's disease 
(Leprosy) 1             1   2 1       1 1   1   1   
  Hantavirus 
syndromes             2 1 2       1         1     1 
 Hepatitis A (viral, 
infectious) 48 53 58 64 106 346 490 400 161 67 41 72 40 50 22 13 48 109 38 11   
 Hepatitis B 
(serum) acute 
/chronic 42 33 36 27 46 74 44 54 44 38 24 20 27 17 32 21/35 269 25/226 293 15/183 15/182 
Hepatitis B 
(perinatal)                               1   1   1   
  Hepatitis C or 
unspecified 14 12 12 25 1 43           1 1           262 156 48 
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*it includes cases starting 2011
Notifiable 
diseases 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
  HIV (diagnosis)               96 84 92 95 105 89 105 113 107 125 101 126 114 120 
  Legionellosis 12 18 19 34 21 11 12 11 17 15 8 13 12 8 8 13 12 21 24 16 11 
  Listeria 
monocytogens           1   2 6 2 3 5   3 7 6 8 1 4 3 5 
  Lyme disease 22 33 8 17 16 19 8 27 24 34 36 42 58 56 91 97 124 109 108 87 100 
  Malaria 7 5 5 5 3 3 10 8 11 2 9 4 6 5 9 2 3 12 10 14 22 
Measles (Rubeola) 17 1   7   1               3         1   1 
  Meningococcal 
invasive disease 15 18 28 25 31 56 47 46 42 37 32 29 28 17 19 20 15 19 16 10 14 
Mumps 23 13 11 16 11 3 10 11 8 8 1 1 2 2 6 1,963 27 24 15 38 8 
Pertussis 
(whooping cough) 26 11 38 23 11 32 207 78 111 67 167 230 182 1066 1106 342 150 257 235 705 232 
  Plague                                           
Poliomyelitis 1                                         
  Psittacosis 3 2 2               3       1             
Rabies, animal 155 175 78 90 141 237 160 153 159 81 83 74 105 100 108 57 31 29 35 27   
Rabies, human                       1                  25 
  Rocky Mountain 
spotted fever 1 3 7 1   1 2 2 1 2 5 7 3 2 7 5 17 8 5 5 7 
Rubella (German 
Measles) 6 3             30   1                     
  Salmonellosis 304 339 242 404 433 335 296 375 260 373 339 509 413 435 410 475 477 425 408 530 448 
  Shigellosis 33 46 68 338 351 151 90 69 74 569 367 122 93 64 103 134 109 214 53 57 18 
Syphilis   154 175 235 171 91 65 25 31 54 43 56 46 36 28 88 27 75 65 68 70 
Tetanus   1 1 1     1 1   1   1     1         1   
  Toxic Shock 
Syndrome 7 7 7 8 5 4 3 4 4 4 1 3 5 5 5     1 2 1 1 
  Trichinosis 1     1 6           3       1             
Tuberculosis 71 49 58 66 67 70 74 55 58 37 42 31 40 47 55 36   46 42 48 40 
Tularemia                                     1   3 
Typhoid fever   1       1 1   1       2       1 6   3 4 
  West Nile virus                       52 147 23 37 37 30 5 5 9 9 
  Yellow Fever                                     2     
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Table 13. Salmonella serotypes reported, 2011 
Salmonella Serotypes by Frequency 
Salmonella Serotype Cases   Serotype Cases 
Salmonella Agona           5 Salmonella Miami 1 
Salmonella Albany 1 Salmonella Minnesota   1 
Salmonella Anatum 2 Salmonella Monophasic      1 
Salmonella Bareilly 3 Salmonella Montevideo      15 
Salmonella Barranquilla 1 Salmonella Muenchen 9 
Salmonella Barranquilla 1 Salmonella Muenster        1 
Salmonella Berta 11 Salmonella Newport        16 
Salmonella Bovismorbificans 4 Salmonella Obugu 1 
Salmonella Braenderup 10 Salmonella Oranienburg     5 
Salmonella Bredeney 2 Salmonella Ouakam 1 
Salmonella Coeln 1 Salmonella Panama 1 
Salmonella Concord 1 Salmonella Paratyphi B var Java 1 
Salmonella Cotham 2 Salmonella Reading 1 
Salmonella Derby         1 Salmonella Saintpaul       3 
Salmonella Dublin 1 Salmonella Sandiego 1 
Salmonella Eastbourne 1 Salmonella Sangera 1 
Salmonella Enteritidis    124 Salmonella Schwarzengrund 1 
Salmonella Hartford 8 Salmonella Stanley 1 
Salmonella Havana 1 Salmonella Species 1 
Salmonella Heidelberg       8 Salmonella Subspecies I 48 
Salmonella Hvittingfoss 1 Salmonella Subspecies IIIa 1 
Salmonella Infantis        13 Salmonella Subspecies IIIb 3 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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Salmonella Javiana      6 Salmonella Thompson        6 
Salmonella Johannesburg 1 Salmonella Typhi 6 
Salmonella Kentucky 1 Salmonella Typhimurium     58 
Salmonella Lagos 1 Salmonella Typhimurium Var 
Copenhagen 
10 
Salmonella Litchfield 7   Unknown 33 
Salmonella Manhattan 1 Total   448 
Salmonella Mbandaka         2    
 
 
 
 
Table 14. Shigella serogroups,  1991-2011 
Shigella  
Serogroups 
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Boydii   1     1 1       4 6 2   3 1 1 0 1 1 2 1 
Dysenteriae 1 1       1                   1 0 0 0 0 0 
Flexneri 8 8 8   3 13 12 6 7 10 7 11 5 8 7 15 9 11 7 6 4 
Group B           3   1 1           3   2 0 0 0 0 
Group C       1                         2 0 0 0 0 
Group D   1   4 3 5   1         1       1 1 0 0 0 
Sonnei 24 33 50 199 119 116 62 44 55 514 306 63 62 41 58 110 97 136 45 49 10 
Unknown                   41 46 46 25 12 7 7 0 0 0 0 3 
TOTAL 
CASES 
33 46 68 338 351 151 90 69 74 569 365 122 93 64 78 134 109 214 53 57 18 
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Table 15. Iowa children born in 2005 and tested for blood lead levels before the age of six years by county (as of 12/31/2011) 
 COUNTY  2005 BIRTHS   TESTED   %TESTED   >=10μG/dl   %>=10μG/dl   COUNTY  2005 BIRTHS   TESTED   %TESTED   >=10μG/dl   %>=10μG/dl  
 Adair  86 86 100.0 4 4.7  Des Moines  500 500 100.0 40 8.0 
 Adams  42 42 100.0 7 16.7  Dickinson  153 153 100.0 1 0.7 
 Allamakee  206 206 100.0 8 3.9  Dubuque  1125 1047 93.1 16 1.5 
 Appanoose  184 144 78.3 5 3.5  Emmet  158 143 90.5 7 4.9 
 Audubon  73 73 100.0 5 6.8  Fayette  250 250 100.0 14 5.6 
 Benton  291 291 100.0 7 2.4  Floyd  218 192 88.1 7 3.6 
 Black Hawk  1683 1683 100.0 73 4.3  Franklin  128 128 100.0 10 7.8 
 Boone  310 310 100.0 15 4.8  Fremont  90 90 100.0 5 5.6 
 Bremer  273 273 100.0 5 1.8  Greene  93 93 100.0 5 5.4 
 Buchanan  298 247 82.9 8 3.2  Grundy  123 123 100.0 2 1.6 
 Buena Vista  292 292 100.0 13 4.5  Guthrie  127 114 89.8 4 3.5 
 Butler  171 171 100.0 4 2.3  Hamilton  185 185 100.0 4 2.2 
 Calhoun  100 95 95.0 4 4.2  Hancock  155 155 100.0 3 1.9 
 Carroll  269 269 100.0 17 6.3  Hardin  207 207 100.0 12 5.8 
 Cass  170 164 96.5 7 4.3  Harrison  177 177 100.0 3 1.7 
 Cedar  194 194 100.0 13 6.7  Henry  246 246 100.0 14 5.7 
 Cerro Gordo  471 471 100.0 17 3.6  Howard  131 131 100.0 5 3.8 
 Cherokee  113 113 100.0 6 5.3  Humboldt  121 115 95.0 2 1.7 
 Chickasaw  179 163 91.1 6 3.7  Ida  81 73 90.1 8 11.0 
 Clarke  132 132 100.0 2 1.5  Iowa  200 195 97.5 7 3.6 
 Clay  200 200 100.0 6 3.0  Jackson  198 198 100.0 4 2.0 
 Clayton  190 190 100.0 6 3.2  Jasper  474 468 98.7 9 1.9 
 Clinton  623 623 100.0 15 2.4 Jefferson  171 163 95.3 3 1.8 
 Crawford  212 212 100.0 4 1.9  Johnson  1457 1457 100.0 12 0.8 
 Dallas  797 797 100.0 14 1.8  Jones  228 228 100.0 5 2.2 
 Davis  137 95 69.3 2 2.1  Keokuk  125 111 88.8 9 8.1 
 Decatur  101 94 93.1 4 4.3  Kossuth  181 181 100.0 4 2.2 
 Delaware  210 185 88.1 3 1.6  Lee  407 407 100.0 15 3.7 
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COUNTY 2005 BIRTHS TESTED %TESTED >=10μG/dl %>=10μG/dl COUNTY 2005 BIRTHS TESTED %TESTED >=10μG/dl %>=10μG/dl 
 Linn  2783 2714 97.5 69 2.5  Poweshiek  195 195 100.0 10 5.1 
 Louisa  129 129 100.0 3 2.3  Ringgold  79 68 86.1 3 4.4 
 Lucas  120 100 83.3 3 3.0  Sac  120 120 100.0 15 12.5 
 Lyon  169 144 85.2 2 1.4  Scott  2317 2317 100.0 79 3.4 
 Madison  189 189 100.0 6 3.2  Shelby  101 101 100.0 1 1.0 
 Mahaska  306 306 100.0 10 3.3  Sioux  479 479 100.0 17 3.5 
 Marion  424 423 99.8 4 0.9  Story  945 945 100.0 10 1.1 
 Marshall  612 612 100.0 44 7.2  Tama  256 256 100.0 13 5.1 
 Mills  197 171 86.8 2 1.2  Taylor  79 79 100.0 13 16.5 
 Mitchell  147 122 83.0 2 1.6  Union  152 152 100.0 26 17.1 
 Monona  95 95 100.0 8 8.4  Van Buren  98 78 79.6 6 7.7 
 Monroe  76 76 100.0 1 1.3  Wapello  504 504 100.0 32 6.3 
 Montgomery  142 142 100.0 7 4.9  Warren  549 549 100.0 3 0.5 
 Muscatine  587 587 100.0 13 2.2  Washington  265 249 94.0 10 4.0 
 O'Brien  184 184 100.0 11 6.0  Wayne  76 76 100.0 4 5.3 
 Osceola  73 73 100.0 5 6.8  Webster  474 474 100.0 17 3.6 
 Page  167 167 100.0 18 10.8  Winnebago  120 120 100.0 3 2.5 
 Palo Alto  121 106 87.6 5 4.7  Winneshiek  210 210 100.0 4 1.9 
 Plymouth  313 313 100.0 8 2.6  Woodbury  1578 1578 100.0 93 5.9 
 Pocahontas  88 86 97.7 2 2.3  Worth  81 81 100.0 6 7.4 
 Polk  6567 6567 100.0 126 1.9  Wright  165 165 100.0 7 4.2 
 Pottawattamie  1227 987 80.4 13 1.3  TOTALS  39275 38434 97.9 1244 3.2 
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Table 16. 2011 Iowa adult blood testing summary by county (as of 03/30/12) 
COUNTY # tested # BLL result > 10 µg/dL COUNTY # tested  # BLL result > 10 µg/dL COUNTY   # tested # BLL result > 10 µg/dL 
Adair  6 0 Floyd  11 <5 Monona <5 0 
Adams 5 <5 Franklin 7 0 Monroe 13 <5 
Allamakee <5 0 Fremont 9 <5 Montgomery 49 30 
Appanoose 51 38 Greene 6 0 Muscatine 53 <5 
Audubon <5 <5 Grundy 7 <5 O’Brien <5 0 
Benton 15 <5 Guthrie <5 0 Osceola <5 0 
Black Hawk  98 <5 Hamilton 13 0 Page 24 12 
Boone  19 0 Hancock 5 0 Palo Alto <5 0 
Bremer  10 0 Hardin 9 0 Plymouth 10 0 
Buchanan  110 29 Harrison 9 <5 Pocahontas <5 <5 
Buena Vista <5 0 Henry 13 0 Polk 291 8 
Butler 10 0 Howard 10 <5 Pottawattamie 35 <5 
Calhoun <5 0 Humboldt 5 0 Poweshiek 9 <5 
Carroll 15 <5 Ida <5 0 Ringgold <5 0 
Cass  15 11 Iowa 12 <5 Sac 10 0 
Cedar 13 <5 Jackson 21 8 Scott  253 18 
Cerro Gordo 39 0 Jasper 14 0 Shelby <5 <5 
Cherokee <5 0 Jefferson 178 53 Sioux 5 0 
Chickasaw  7 0 Johnson 79 <5 Story 45 <5 
Clarke 5 <5 Jones 20 <5 Tama 8 <5 
Clay <5 0 Keokuk 22 5 Taylor <5 0 
Clayton 55 47 Kossuth <5 0 Union 12 <5 
Clinton 88 <5 Lee 53 <5 Van Buren 5 <5 
Crawford <5 0 Linn 174 15 Wapello 35 11 
Dallas 31 <5 Louisa 12 0 Warren 27 <5 
Davis 6 <5 Lucas 41 25 Washington 18 <5 
Decatur 6 5 Lyon <5 0 Wayne 141 108 
Delaware 253 220 Madison 12 0 Webster 24 <5 
Des Moines 33 <5 Mahaska 48 8 Winnebago 5 0 
Dickinson 9 0 Marion 17 <5 Winneshiek <5 0 
Dubuque 159 99 Marshall 17 <5 Woodbury 62 <5 
Emmet <5 0 Mills 15 <5 Worth <5 0 
Fayette  45 10 Mitchell <5 0 Total including suppressed data
 
3155 832 
Based on highest test result in 2011 per adult (16 yo at time of test) residing in Iowa. Numbers 1-4 are suppressed and shown as <5. An elevated blood lead level (EBL) is considered a venous result greater than or equal to 10 micrograms per deciliter (µg/dL). 
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Table 17. Common notifiable diseases by county, 2011 
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ADAIR 0 0 0 11 2 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
ADAMS 0 0 0 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 
ALLAMAKEE 0 * 12 18 5 1 0 1 0 0 0 0 1 0 0 11 0 0 7 0 0 8 1 0 1 0 
APPANOOSE 0 0 2 31 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 
AUDUBON 0 0 0 23 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
BENTON 0 0 13 47 3 5 0 6 7 0 0 0 3 0 0 2 0 0 3 0 0 7 0 0 0 0 
BLACK HAWK * * 9 896 0 9 0 8 265 0 1 0 7 2 0 3 0 1 5 0 0 23 2 2 5 0 
BOONE 0 0 7 51 2 0 0 2 3 0 2 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 
BREMER 0 0 7 42 0 2 0 1 5 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 
BUCHANAN 0 0 11 33 1 1 0 3 7 0 0 0 1 0 0 0 0 0 5 0 0 4 0 0 0 0 
BUENA VISTA 0 * 8 46 2 0 0 2 3 0 1 1 9 0 0 0 0 0 0 0 1 1 4 1 1 0 
BUTLER 0 0 5 28 0 3 0 2 2 0 0 0 0 0 0 1 0 0 0 1 0 5 0 0 0 0 
CALHOUN 0 0 1 20 0 1 0 1 7 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
CARROLL 0 0 3 38 2 1 0 3 2 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 
CASS 0 0 0 41 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 
CEDAR * * 2 39 2 1 0 0 3 0 0 0 1 0 0 1 0 0 4 0 0 4 0 0 0 0 
CERRO GORDO * * 7 126 0 3 0 0 16 0 0 0 3 0 0 0 1 0 1 0 0 6 0 0 0 1 
CHEROKEE * * 1 12 0 0 0 0 1 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 
CHICKASAW 0 0 4 17 1 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
CLARKE 0 0 1 24 1 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
CLAY * * 13 49 1 2 0 2 1 0 0 0 1 0 2 0 0 0 0 0 0 2 0 1 0 0 
CLAYTON 0 0 3 19 6 2 0 1 3 0 0 0 0 0 0 13 0 0 1 0 0 1 0 1 0 0 
CLINTON * * 9 173 5 1 0 1 30 0 0 2 2 1 0 1 1 1 4 0 0 8 0 2 0 0 
CRAWFORD 0 * 3 63 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 
DALLAS * 4 20 127 4 5 0 14 18 0 0 0 3 1 0 0 0 0 8 1 0 10 0 0 1 0 
Iowa Department of Public Health 
 46 
 
  
A
ID
S 
(d
ia
gn
o
si
s)
 
H
IV
 (
d
ia
gn
o
si
s)
 
C
A
M
P
Y 
C
H
LA
M
YD
IA
 
C
R
YP
TO
SP
O
R
A
 
E.
C
O
LI
 S
H
G
T 
EH
R
LI
C
H
 (
H
M
E)
 
G
IA
R
D
IA
 
G
O
N
O
R
R
H
EA
 
H
U
S 
H
EP
 A
 
H
EP
 B
, A
C
U
TE
 
H
EP
 B
, C
H
R
O
N
 
LE
G
IO
N
 
LI
ST
ER
IA
 
LY
M
E 
M
EN
IN
G
O
.I
N
F 
M
U
M
P
S 
P
ER
TU
SS
IS
 
R
A
B
IE
S 
(A
N
IM
A
L)
 
R
M
SF
 
SA
LM
 
SH
IG
EL
LA
 
SY
P
H
IL
IS
 
TB
 
W
ES
T 
N
IL
E 
V
IR
U
S 
DAVIS 0 0 5 13 0 2 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
DECATUR 0 0 5 23 1 1 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 4 0 1 0 0 
DELAWARE * 0 11 40 5 7 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 
DES MOINES * * 13 227 9 3 0 3 63 0 0 1 2 0 0 2 0 0 2 0 0 9 0 1 0 0 
DICKINSON * 0 3 18 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 1 0 2 0 0 1 0 
DUBUQUE * 5 42 346 16 9 0 9 94 1 0 0 5 0 0 12 1 0 22 0 0 23 1 0 1 0 
EMMET 0 0 3 21 2 0 0 1 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 
FAYETTE 0 0 8 52 3 0 0 0 2 0 0 0 0 0 0 3 0 0 1 0 0 5 0 0 0 0 
FLOYD 0 0 3 43 1 0 0 2 4 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
FRANKLIN 0 0 0 26 0 1 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
FREMONT 0 0 0 6 3 0 1 2 1 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 1 
GREENE 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 
GRUNDY * 0 2 28 0 2 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
GUTHRIE 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
HAMILTON 0 0 2 30 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 
HANCOCK 0 0 3 13 1 1 0 0 1 0 0 0 0 1 0 1 0 0 3 0 0 2 0 0 0 0 
HARDIN * * 5 44 1 0 1 1 4 0 0 0 0 0 0 1 0 0 3 1 0 3 0 1 0 0 
HARRISON 0 0 4 31 1 0 0 3 4 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 3 
HENRY 0 0 0 58 5 0 0 3 4 0 0 0 2 0 0 0 0 2 6 0 0 2 0 0 0 0 
HOWARD 0 0 6 17 2 2 0 2 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
HUMBOLDT 0 0 2 13 2 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
IDA 0 0 3 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 
IOWA 0 0 1 42 2 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 2 0 1 0 0 
JACKSON 0 0 27 38 5 2 0 1 1 0 0 0 2 0 0 4 0 0 4 0 0 5 0 0 0 0 
JASPER 0 0 5 76 13 3 0 2 6 0 0 0 0 0 0 0 0 0 1 1 0 6 0 0 0 0 
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JEFFERSON 0 0 4 21 5 0 0 6 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 
JOHNSON 9 11 30 750 9 7 0 17 106 0 0 0 20 0 0 13 0 0 7 0 0 18 1 6 4 0 
JONES 0 * 14 35 6 3 0 1 4 0 0 0 0 0 0 0 0 0 4 0 0 1 0 0 0 0 
KEOKUK 0 * 1 21 1 0 0 1 1 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 
KOSSUTH 0 0 3 19 0 2 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 
LEE * 0 2 131 2 5 0 3 8 0 0 0 0 0 0 0 0 0 0 0 1 5 0 0 0 0 
LINN * 9 38 1097 27 8 1 20 261 0 1 0 17 0 0 10 2 1 12 2 0 27 0 9 3 0 
LOUISA 0 0 4 33 3 0 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 2 0 
LUCAS 0 0 2 15 1 4 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 
LYON 0 0 12 10 4 5 0 1 1 1 0 0 0 0 1 0 0 0 1 1 0 9 0 0 0 0 
MADISON 0 0 1 17 0 4 0 1 2 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 
MAHASKA 0 0 2 64 2 1 0 2 2 0 0 0 0 0 0 0 0 0 9 0 0 4 0 0 0 0 
MARION 0 0 10 60 5 1 0 4 3 0 0 0 1 0 0 1 0 0 2 0 0 5 0 0 0 0 
MARSHALL * * 11 157 1 2 0 1 15 0 0 1 5 0 0 0 1 0 0 0 0 5 0 0 1 0 
MILLS 0 * 6 31 1 3 0 3 5 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 2 
MITCHELL 0 0 0 12 1 2 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 
MONONA 0 0 2 14 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
MONROE 0 0 2 19 4 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
MONTGOMERY 0 * 3 14 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 2 0 0 0 0 
MUSCATINE * 0 4 158 2 1 0 2 20 0 0 0 1 0 0 1 0 0 8 1 0 5 0 1 0 0 
O'BRIEN 0 0 13 22 2 2 0 4 0 0 0 0 0 0 0 0 0 0 2 0 0 3 0 0 0 0 
OSCEOLA 0 0 6 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
PAGE 0 0 2 33 3 1 1 2 1 0 0 0 0 1 0 0 0 0 0 1 0 4 0 0 0 0 
PALO ALTO 0 0 2 17 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 
PLYMOUTH 0 0 10 49 10 2 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 
POCAHONTAS 0 0 2 9 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 
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POLK 25 47 108 2053 34 17 1 62 513 3 1 5 46 1 0 3 2 2 21 2 0 56 6 22 11 0 
POTTAWATTAMIE * 6 23 318 7 5 0 4 77 2 0 2 5 3 1 0 2 0 4 0 0 6 0 0 0 2 
POWESHIEK 0 0 4 43 4 3 0 1 3 0 0 0 1 0 0 0 0 0 0 0 0 2 0 1 0 0 
RINGGOLD 0 0 1 5 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 
SAC 0 0 2 8 0 2 0 1 3 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 1 0 
SCOTT 6 9 20 936 10 7 1 6 215 0 0 1 11 1 0 3 0 0 13 0 1 13 1 6 0 0 
SHELBY * * 2 20 6 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
SIOUX 0 * 19 39 31 5 0 8 0 0 0 0 2 0 0 0 0 0 6 2 1 9 0 0 0 0 
STORY 0 * 17 293 7 4 0 1 25 2 0 1 11 0 0 1 1 0 4 2 0 7 0 1 3 0 
TAMA 0 0 3 72 1 2 0 1 4 0 0 0 0 0 0 0 0 0 1 0 0 5 0 0 0 0 
TAYLOR 0 0 0 8 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 
UNION 0 0 1 39 1 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 
VAN BUREN * 0 1 10 5 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 
WAPELLO 0 * 5 135 18 1 0 4 9 0 0 1 2 0 0 1 0 0 0 1 0 2 0 1 2 0 
WARREN 0 0 10 79 5 4 0 4 15 2 0 0 0 0 0 2 0 0 3 0 0 4 0 1 0 0 
WASHINGTON 0 0 5 42 0 3 0 1 9 0 0 0 1 0 0 0 1 0 9 0 0 2 0 0 0 0 
WAYNE 0 0 0 10 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 
WEBSTER 0 0 8 183 13 0 0 7 26 0 0 0 0 0 0 0 1 0 0 0 0 5 0 0 0 0 
WINNEBAGO 0 0 3 20 0 0 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
WINNESHIEK 0 0 12 27 3 4 0 0 2 0 0 0 0 0 0 6 1 0 1 1 0 3 0 1 0 0 
WOODBURY 4 4 17 510 12 0 0 9 41 0 0 0 4 0 0 0 0 0 34 0 0 22 1 4 2 0 
WORTH * 0 4 7 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
WRIGHT 0 0 2 19 0 0 0 0 4 0 0 0 3 0 0 0 0 0 2 0 0 2 0 0 0 0 
Total 74 120 747 10928 364 189 8 271 1966 13 8 15 182 11 5 100 14 8 232 8 7 448 18 70 40 9 
*in the ‘HIV (diagnoses)’ column indicates only 1-3 HIV diagnoses reported for that county 
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